Inaugural Psychiatry Summit 2022

Click here to register now on the website of PCE, our sister company. Please note, you will need to create a PCE account to register if you do not already have one. Setting up an account is quick and easy.

The Inaugural Psychiatry Summit 2022 includes 3 full days of live, virtual, cutting edge programs! VIP pricing of $99 available for a limited time (early bird rate $149; regular rate $199). The summit sets the standard for timely, unbiased, evidence-based education from the world’s leading experts.

Join psychiatrists, NPs, PAs, and other healthcare professionals from around the world for this unique virtual opportunity to enhance knowledge and improve patient outcomes. Engage with U.S.-based and international experts as they discuss the latest advances in the diagnosis and treatment of a wide range of psychiatric illnesses, debate controversies in the field and share their clinical pearls. Earn up to 15 hours of CME/CE credit.


Tentative topics include:

• Mental Health Parity: Why Are We Still Waiting?

• Why Do Schizophrenia Patients Relapse?

• New Mechanisms / New Medications for Psychoses

• Management of Early Phase Psychosis

• Digital Technology in Psychiatry

• Telemedicine in Psychiatry

• The Treatment of Aggressive Behavior

• Medical Comorbidities in Psychiatric Patients

• Social and Environmental Determinants of Health

• Treatment of Bipolar-Unipolar as a Spectrum Disorder

• Pharmacological Strategies for Ultra-Treatment-Resistant

• Targeting Anxiety Symptoms in Mood Disorder Patients

• Pharmacotherapy of Affective Instability and Distress

• Iterative Pharmacotherapy in MDD: When to Switch vs

• Anti-suicide Pharmacotherapies

• Revisiting Older-Generation Psychotropics in 2022

• Differentiating and Treating Negative Symptoms vs
   Depression in Schizophrenia

• Utility of Therapeutic Drug Monitoring in Psychiatry


Scientific Committee
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine, Mount Sinai

Scientific Committee
John M. Kane, MD

Chairman of Psychiatry
Hofstra Northwell School of Medicine

Scientific Committee
Prakash Masand, MD

Chief Medical Officer, Neuroscience
Global Medical Education, a Clinical Care Options Company
New York, New York

Scientific Committee
Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada

Scientific Committee
Alan F. Schatzberg, MD

Kenneth T. Norris, Jr., Professor
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Program Overview
The primary purpose of this activity is to improve participants’ competence in addressing the most important and most current challenges in the treatment of psychiatric illness by providing a focused upate on recent advances and key issues.

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness.

Target Audience
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • TBD


**Credit/Contact hours are subject to change**

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 15.0 AMA PRA Category 1 CreditsTM. Psysicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 15.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 15.0 contact hours (1.5 CEUs) of the Accreditation Council for Pharmacy Education. UAN will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 15.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC (CCO) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CCO maintains responsibility for this course. Social workers completing this course will receive 15.0 continuing education credits.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.